busulfan has been researched along with Complication, Postoperative in 43 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Busulfan (Bu)-based preparative regimens have not been extensively investigated in Hodgkin disease (HD)." | 7.73 | Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation. ( Andrèsen, S; Avalos, B; Bolwell, B; Copelan, E; Elder, P; Farag, S; Kalaycio, M; Lin, T; Marcucci, G; Penza, S; Pohlman, B; Sobecks, R; Wadehra, N, 2006) |
| " She had a history of polycythemia vera and had been treated with a daily dose of 500mg hydroxyurea (HU) for six years." | 7.72 | Huge post-operative ulcer following hydroxyurea therapy in a patient with polycythemia vera. ( Iwata, K; Nakano, M; Ogawa, H; Ogura, S; Seki, K; Tasaka, T; Yokota, K, 2003) |
| " Cyclosporine alone or cyclosporine with short-term methotrexate was randomized for graft-versus-host disease prophylaxis." | 5.12 | Prospective phase II trial to evaluate the complications and kinetics of chimerism induction following allogeneic hematopoietic stem cell transplantation with fludarabine and busulfan. ( Hara, M; Hino, M; Hori, A; Kami, M; Kanda, Y; Kim, SW; Mineishi, S; Mori, S; Ohashi, Y; Saito, AM; Suzuki, R; Takami, A; Takaue, Y; Takemoto, Y; Taniguchi, S; Yamaguchi, M; Yoshida, T, 2007) |
| "Busulfan (Bu)-based preparative regimens have not been extensively investigated in Hodgkin disease (HD)." | 3.73 | Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation. ( Andrèsen, S; Avalos, B; Bolwell, B; Copelan, E; Elder, P; Farag, S; Kalaycio, M; Lin, T; Marcucci, G; Penza, S; Pohlman, B; Sobecks, R; Wadehra, N, 2006) |
| " She had a history of polycythemia vera and had been treated with a daily dose of 500mg hydroxyurea (HU) for six years." | 3.72 | Huge post-operative ulcer following hydroxyurea therapy in a patient with polycythemia vera. ( Iwata, K; Nakano, M; Ogawa, H; Ogura, S; Seki, K; Tasaka, T; Yokota, K, 2003) |
| "Such opportunistic viral infections, leading to either interstitial pneumonia or hemorrhagic gastroenteritis, are the major threat in the early recovery phase after engraftment has taken place." | 2.37 | Infections and immunodeficiency in bone marrow transplantation. ( Tutschka, PJ, 1988) |
| " In an effort to minimize these adverse effects, we conducted bone marrow transplantation (BMT) from unrelated volunteer donors using a conditioning regimen without BU or TBI." | 1.40 | Fludarabine, cytarabine, granulocyte colony-stimulating factor and melphalan (FALG with L-PAM) as a reduced toxicity conditioning regimen in children with acute leukemia. ( Kato, K; Matsumoto, K; Matsuyama, T; Yoshida, N, 2014) |
| "A total of 57 patients with Wiskott-Aldrich syndrome (WAS) were studied after undergoing stem cell transplantation (SCT) in Japan between January 1985 and December 2004." | 1.33 | Outcome in patients with Wiskott-Aldrich syndrome following stem cell transplantation: an analysis of 57 patients in Japan. ( Ariga, T; Kanegane, H; Kato, S; Kawa, K; Kobayashi, R; Miyawaki, T; Morio, T; Nagatoshi, Y; Nonoyama, S; Tabuchi, K; Tsuchida, M; Tsuchiya, S; Yabe, H, 2006) |
| "Hyperbilirubinemia was graded according to a report by Hogan et al (Blood." | 1.33 | Hepatic injury following reduced intensity unrelated cord blood transplantation for adult patients with hematological diseases. ( Fujiwara, M; Hori, A; Kami, M; Kanda, Y; Komatsu, T; Koyama, R; Kusumi, E; Masuoka, K; Matsumura, T; Miyakoshi, S; Murashige, N; Seki, K; Tanaka, Y; Taniguchi, S; Wake, A; Yuji, K, 2006) |
| "Ninety-nine patients with acute nonlymphocytic leukemia (ANLL) received HLA-identical bone marrow transplants (BMTs) from sibling donors after preparation with high doses of busulfan and cyclophosphamide." | 1.28 | Allogeneic bone marrow transplantation after high-dose busulfan and cyclophosphamide in patients with acute nonlymphocytic leukemia. ( Ambinder, RF; Beschorner, WB; Braine, HG; Burns, WH; Geller, RB; Piantadosi, S; Saral, R; Vogelsang, GB; Wingard, JR; Zahurak, M, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (41.86) | 18.7374 |
| 1990's | 1 (2.33) | 18.2507 |
| 2000's | 17 (39.53) | 29.6817 |
| 2010's | 7 (16.28) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qin, CJ | 1 |
| Liu, LJ | 1 |
| Zhang, ZM | 1 |
| Luo, L | 1 |
| Lai, YR | 1 |
| Li, QC | 1 |
| Gazourian, L | 1 |
| Rogers, AJ | 1 |
| Ibanga, R | 1 |
| Weinhouse, GL | 1 |
| Pinto-Plata, V | 1 |
| Ritz, J | 1 |
| Soiffer, RJ | 1 |
| Antin, JH | 1 |
| Washko, GR | 1 |
| Baron, RM | 1 |
| Ho, VT | 1 |
| Kato, K | 1 |
| Yoshida, N | 1 |
| Matsumoto, K | 1 |
| Matsuyama, T | 1 |
| Wilhelmsson, M | 1 |
| Vatanen, A | 1 |
| Borgström, B | 1 |
| Gustafsson, B | 1 |
| Taskinen, M | 1 |
| Saarinen-Pihkala, UM | 1 |
| Winiarski, J | 1 |
| Jahnukainen, K | 1 |
| Schuetz, C | 1 |
| Hoenig, M | 1 |
| Gatz, S | 1 |
| Speth, F | 1 |
| Benninghoff, U | 1 |
| Schulz, A | 1 |
| Debatin, KM | 1 |
| Friedrich, W | 1 |
| Shigematsu, A | 1 |
| Yasumoto, A | 1 |
| Yamamoto, S | 1 |
| Sugita, J | 1 |
| Kondo, T | 1 |
| Onozawa, M | 1 |
| Kahata, K | 1 |
| Endo, T | 1 |
| Ota, S | 1 |
| Sato, N | 1 |
| Takahata, M | 1 |
| Okada, K | 1 |
| Tanaka, J | 1 |
| Hashino, S | 1 |
| Nishio, M | 1 |
| Koike, T | 1 |
| Asaka, M | 1 |
| Imamura, M | 1 |
| Hamadani, M | 1 |
| Blum, W | 1 |
| Phillips, G | 1 |
| Elder, P | 2 |
| Andritsos, L | 1 |
| Hofmeister, C | 1 |
| O'Donnell, L | 1 |
| Klisovic, R | 1 |
| Penza, S | 2 |
| Garzon, R | 1 |
| Krugh, D | 1 |
| Lin, T | 2 |
| Bechtel, T | 1 |
| Benson, DM | 1 |
| Byrd, JC | 1 |
| Marcucci, G | 2 |
| Devine, SM | 1 |
| Ulrickson, M | 1 |
| Aldridge, J | 1 |
| Kim, HT | 1 |
| Hochberg, EP | 1 |
| Hammerman, P | 1 |
| Dube, C | 1 |
| Attar, E | 1 |
| Ballen, KK | 1 |
| Dey, BR | 1 |
| McAfee, SL | 1 |
| Spitzer, TR | 1 |
| Chen, YB | 1 |
| Atallah, E | 1 |
| Abrams, J | 1 |
| Ayash, L | 1 |
| Bentley, G | 1 |
| Abidi, M | 1 |
| Ratanatharathorn, V | 1 |
| Uberti, J | 1 |
| Au, BK | 1 |
| Au, MA | 1 |
| Chien, JW | 1 |
| Ahn, JS | 1 |
| Yang, DH | 1 |
| Jung, SH | 1 |
| Chae, YS | 1 |
| Sohn, SK | 1 |
| Yhim, HY | 1 |
| Kwak, JY | 1 |
| Lee, SR | 1 |
| Kim, YK | 1 |
| Kim, HJ | 1 |
| Lee, JJ | 1 |
| Yokota, K | 1 |
| Tasaka, T | 1 |
| Iwata, K | 1 |
| Ogawa, H | 1 |
| Nakano, M | 1 |
| Seki, K | 2 |
| Ogura, S | 1 |
| Maschan, AA | 1 |
| Trakhtman, PE | 1 |
| Balashov, DN | 1 |
| Shipicina, IP | 1 |
| Skorobogatova, EV | 1 |
| Skvortsova, YV | 1 |
| Dyshlevaja, ZM | 1 |
| Samochatova, EV | 1 |
| Rumiantsev, AG | 1 |
| Parikh, CR | 1 |
| Schrier, RW | 1 |
| Storer, B | 1 |
| Diaconescu, R | 1 |
| Sorror, ML | 1 |
| Maris, MB | 1 |
| Maloney, DG | 1 |
| McSweeney, P | 1 |
| Storb, R | 1 |
| Sandmaier, BM | 1 |
| Rao, PS | 1 |
| Gaziev, J | 1 |
| Sodani, P | 1 |
| Polchi, P | 1 |
| Andreani, M | 1 |
| Lucarelli, G | 1 |
| Merup, M | 1 |
| Lazarevic, V | 1 |
| Nahi, H | 1 |
| Andreasson, B | 1 |
| Malm, C | 1 |
| Nilsson, L | 1 |
| Brune, M | 1 |
| LeBlanc, K | 1 |
| Kutti, J | 1 |
| Birgegård, G | 1 |
| Kobayashi, R | 1 |
| Ariga, T | 1 |
| Nonoyama, S | 1 |
| Kanegane, H | 1 |
| Tsuchiya, S | 1 |
| Morio, T | 1 |
| Yabe, H | 1 |
| Nagatoshi, Y | 1 |
| Kawa, K | 1 |
| Tabuchi, K | 1 |
| Tsuchida, M | 1 |
| Miyawaki, T | 1 |
| Kato, S | 1 |
| Kusumi, E | 1 |
| Kami, M | 2 |
| Kanda, Y | 2 |
| Murashige, N | 1 |
| Fujiwara, M | 1 |
| Koyama, R | 1 |
| Komatsu, T | 1 |
| Hori, A | 2 |
| Tanaka, Y | 1 |
| Yuji, K | 1 |
| Matsumura, T | 1 |
| Masuoka, K | 1 |
| Wake, A | 1 |
| Miyakoshi, S | 1 |
| Taniguchi, S | 2 |
| Rodriguez, R | 1 |
| Nademanee, A | 1 |
| Ruel, N | 1 |
| Smith, E | 1 |
| Krishnan, A | 1 |
| Popplewell, L | 1 |
| Zain, J | 1 |
| Patane, K | 1 |
| Kogut, N | 1 |
| Nakamura, R | 1 |
| Sarkodee-Adoo, C | 1 |
| Forman, SJ | 1 |
| Wadehra, N | 1 |
| Farag, S | 1 |
| Bolwell, B | 1 |
| Kalaycio, M | 1 |
| Avalos, B | 1 |
| Pohlman, B | 1 |
| Sobecks, R | 1 |
| Andrèsen, S | 1 |
| Copelan, E | 1 |
| Yoshimi, A | 1 |
| Mohamed, M | 1 |
| Bierings, M | 1 |
| Urban, C | 1 |
| Korthof, E | 1 |
| Zecca, M | 1 |
| Sykora, KW | 1 |
| Duffner, U | 1 |
| Trebo, M | 1 |
| Matthes-Martin, S | 1 |
| Sedlacek, P | 1 |
| Klingebiel, T | 1 |
| Lang, P | 1 |
| Führer, M | 1 |
| Claviez, A | 1 |
| Wössmann, W | 1 |
| Pession, A | 1 |
| Arvidson, J | 1 |
| O'Marcaigh, AS | 1 |
| van den Heuvel-Eibrink, MM | 1 |
| Starý, J | 1 |
| Hasle, H | 1 |
| Nöllke, P | 1 |
| Locatelli, F | 1 |
| Niemeyer, CM | 1 |
| Saito, AM | 1 |
| Mori, S | 1 |
| Suzuki, R | 1 |
| Mineishi, S | 1 |
| Takami, A | 1 |
| Takemoto, Y | 1 |
| Hara, M | 1 |
| Yamaguchi, M | 1 |
| Hino, M | 1 |
| Yoshida, T | 1 |
| Kim, SW | 1 |
| Ohashi, Y | 1 |
| Takaue, Y | 1 |
| Muñoz, A | 1 |
| Olivé, T | 1 |
| Martinez, A | 1 |
| Bureo, E | 1 |
| Maldonado, MS | 1 |
| Diaz de Heredia, C | 1 |
| Sastre, A | 1 |
| Gonzalez-Vicent, M | 1 |
| Okuma, K | 1 |
| Ota, K | 1 |
| Gyger, M | 1 |
| Perreault, C | 1 |
| Boileau, J | 1 |
| Aymard, JP | 1 |
| Bonny, Y | 1 |
| Lacombe, M | 1 |
| Lavallee, R | 1 |
| d'Angelo, G | 1 |
| Tawil, E | 1 |
| Beschorner, WE | 1 |
| Karrer, K | 1 |
| Pridun, N | 1 |
| Denck, H | 1 |
| Sighart, H | 1 |
| Vermylen, C | 1 |
| Cornu, G | 1 |
| Philippe, M | 1 |
| Ninane, J | 1 |
| Borja, A | 1 |
| Latinne, D | 1 |
| Ferrant, A | 1 |
| Michaux, JL | 1 |
| Sokal, G | 1 |
| Snover, DC | 1 |
| Weisdorf, S | 1 |
| Bloomer, J | 1 |
| McGlave, P | 1 |
| Weisdorf, D | 1 |
| Tutschka, PJ | 3 |
| Copelan, EA | 2 |
| Kapoor, N | 2 |
| Uharek, L | 1 |
| Gassmann, W | 1 |
| Fleischhauer, D | 1 |
| Wottge, HU | 1 |
| Loeffler, H | 1 |
| Müller-Ruchholtz, W | 1 |
| Grever, MR | 1 |
| Geller, RB | 1 |
| Saral, R | 1 |
| Piantadosi, S | 1 |
| Zahurak, M | 1 |
| Vogelsang, GB | 1 |
| Wingard, JR | 1 |
| Ambinder, RF | 1 |
| Beschorner, WB | 1 |
| Braine, HG | 1 |
| Burns, WH | 1 |
| Frappaz, D | 1 |
| Freycon, F | 1 |
| Richard, O | 1 |
| Galacteros, F | 1 |
| Bertheas, MF | 1 |
| Dutou, L | 1 |
| Bouteille, M | 1 |
| Ogino, T | 1 |
| Ohshio, I | 1 |
| Rudowski, W | 1 |
| Klawe, Z | 1 |
| Woźniewska, M | 1 |
| Ziemski, JM | 1 |
| Cardamone, JM | 1 |
| Edson, JR | 1 |
| McArthur, JR | 1 |
| Jacob, HS | 1 |
| Solhaug, JH | 1 |
| Rieche, K | 1 |
| Ravich, RB | 1 |
| Gunz, FW | 1 |
| Thompson, IL | 1 |
| Reed, CS | 1 |
| Vallée, G | 1 |
| Boivin, P | 1 |
| Dormont, J | 1 |
| Soulier, JP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prospective Study of Combined ATG Regimen for Prophylaxis of aGVHD in Matched Sibling Donor PBSCT[NCT02677181] | Phase 4 | 100 participants (Actual) | Interventional | 2016-01-31 | Completed | ||
| Safety and Efficacy of Ibritumomab Tiuxetan (Zevalin®) in Association With a Fludarabine Based Reduced Conditioning Regimen and Allogenic Stem Cell Support in Chemo-sensitive Relapsed CD20 Positive Aggressive Non-Hodgkin's Lymphoma Patients.[NCT00607854] | Phase 2 | 31 participants (Actual) | Interventional | 2008-02-29 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for busulfan and Complication, Postoperative
| Article | Year |
|---|---|
[Pulmonary toxicity of antineoplastic agents--with special reference to current findings on pulmonary toxicity of bleomycin].
Topics: Animals; Antineoplastic Agents; Bleomycin; Busulfan; Cyclophosphamide; Humans; Lung; Mercaptopurine; | 1982 |
Destruction of the intestinal mucosa after bone marrow transplantation and graft-versus-host disease.
Topics: Acute Disease; Bone Marrow Transplantation; Busulfan; Chronic Disease; Combined Modality Therapy; Cy | 1984 |
Infections and immunodeficiency in bone marrow transplantation.
Topics: Anti-Bacterial Agents; Bacterial Infections; Bone Marrow Transplantation; Busulfan; Graft vs Host Di | 1988 |
[Major beta-thalassemia and bone marrow allograft. Two cases and a study of the literature].
Topics: Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Humans; Infant; Male; Postoperative Complic | 1987 |
[The cancerogenicity of antineoplastic agents].
Topics: Aged; Alkylating Agents; Animals; Antimetabolites; Antineoplastic Agents; Busulfan; Female; Humans; | 1969 |
3 trials available for busulfan and Complication, Postoperative
| Article | Year |
|---|---|
Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignancies.
Topics: Adult; Aged; Animals; Anti-Infective Agents; Antilymphocyte Serum; Busulfan; Disease Susceptibility; | 2009 |
Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Preschool; Combined Modality | 2007 |
Prospective phase II trial to evaluate the complications and kinetics of chimerism induction following allogeneic hematopoietic stem cell transplantation with fludarabine and busulfan.
Topics: Adult; Aged; Busulfan; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Graft vs Hos | 2007 |
35 other studies available for busulfan and Complication, Postoperative
| Article | Year |
|---|---|
[A clinical analysis of hepatic veno-occlusive disease after hematopoietic stem cell transplantation].
Topics: Adolescent; Busulfan; China; Hematopoietic Stem Cell Transplantation; Heparin, Low-Molecular-Weight; | 2018 |
Factors associated with bronchiolitis obliterans syndrome and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Topics: Adult; Allografts; Antilymphocyte Serum; Bronchiolitis Obliterans; Busulfan; Case-Control Studies; C | 2014 |
Fludarabine, cytarabine, granulocyte colony-stimulating factor and melphalan (FALG with L-PAM) as a reduced toxicity conditioning regimen in children with acute leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; C | 2014 |
Adult testicular volume predicts spermatogenetic recovery after allogeneic HSCT in childhood and adolescence.
Topics: Adolescent; Allografts; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Pres | 2014 |
Hematopoietic stem cell transplantation from matched unrelated donors in chronic granulomatous disease.
Topics: Adolescent; Busulfan; Child; Child, Preschool; Chimerism; Cyclophosphamide; Follow-Up Studies; Granu | 2009 |
Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Antigens, Viral; Bone Marrow Transplantation; Busulf | 2009 |
Busulfan and cyclophosphamide (Bu/Cy) as a preparative regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma: a single-institution experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Atrial Fibrillation; Busulfan; Combined | 2009 |
Long term follow-up of allogeneic stem cell transplantation in patients with myelodysplastic syndromes using busulfan, cytosine arabinoside, and cyclophosphamide.
Topics: Adolescent; Adult; Aged; Busulfan; Cyclophosphamide; Cytarabine; Disease-Free Survival; Female; Foll | 2010 |
Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation.
Topics: Adolescent; Adult; Aged; Bone Marrow Transplantation; Bronchiolitis Obliterans; Busulfan; Chronic Di | 2011 |
Autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide as an intensifying frontline treatment in patients with peripheral T cell lymphomas: a multicenter retrospective trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Combined Modality Thera | 2013 |
Huge post-operative ulcer following hydroxyurea therapy in a patient with polycythemia vera.
Topics: Aged; Anti-Bacterial Agents; Busulfan; Combined Modality Therapy; Debridement; Female; Heparin; Hern | 2003 |
Fludarabine, low-dose busulfan and antithymocyte globulin as conditioning for Fanconi anemia patients receiving bone marrow transplantation from HLA-compatible related donors.
Topics: Antilymphocyte Serum; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cytomegaloviru | 2004 |
Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Busulfan; Cohort Studies; Comorbidity; Cyclophosphamid | 2005 |
Nephrotic syndrome in patients with peripheral blood stem cell transplant.
Topics: Acute Kidney Injury; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineop | 2005 |
Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up.
Topics: Adolescent; Adult; Azathioprine; Bone Marrow Transplantation; Busulfan; Chelation Therapy; Clinical | 2005 |
Different outcome of allogeneic transplantation in myelofibrosis using conventional or reduced-intensity conditioning regimens.
Topics: Adult; Antilymphocyte Serum; Antineoplastic Agents; Busulfan; Child, Preschool; Cyclophosphamide; Fe | 2006 |
Outcome in patients with Wiskott-Aldrich syndrome following stem cell transplantation: an analysis of 57 patients in Japan.
Topics: Adolescent; Adult; Age Factors; Antilymphocyte Serum; Bone Marrow Transplantation; Busulfan; Child; | 2006 |
Hepatic injury following reduced intensity unrelated cord blood transplantation for adult patients with hematological diseases.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Busulfan; Chemical and Drug In | 2006 |
Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Busulfan; Cause of Death; Cohort Studies; Cyclophosphamide; Disease-Free Su | 2006 |
Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Combined Modality | 2006 |
Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
Topics: Antilymphocyte Serum; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Graft vs Ho | 2007 |
Restoration of normal hematopoiesis by bone marrow ablation and allogeneic marrow transplantation in a case of Hodgkin's disease therapy-related preleukemia.
Topics: Adult; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Hematopoiesis; Hodgkin Disease; Huma | 1983 |
[Polychemotherapy in patients following radical surgery for bronchial carcinoma].
Topics: Bronchial Neoplasms; Busulfan; Cyclophosphamide; Drug Therapy, Combination; Drug Tolerance; Fluorour | 1977 |
Bone marrow transplantation in sickle cell anaemia.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Bone Marrow Transplantation; Busulfan; Child; Child, Prescho | 1991 |
Nodular regenerative hyperplasia of the liver following bone marrow transplantation.
Topics: Bone Marrow Transplantation; Busulfan; Hepatic Veno-Occlusive Disease; Humans; Hyperplasia; Liver; L | 1989 |
Replacing total body irradiation with busulfan as conditioning of patients with leukemia for allogeneic marrow transplantation.
Topics: Actuarial Analysis; Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Child; Graft vs Host D | 1989 |
Comparison of immunosuppressive agents for prevention of graft rejection in allogeneic bone marrow transplantation.
Topics: Animals; Bone Marrow Transplantation; Busulfan; Cytarabine; Etoposide; Graft Rejection; Immunosuppre | 1989 |
Marrow transplantation following busulfan and cyclophosphamide for chronic myelogenous leukaemia in accelerated or blastic phase.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Child; Cyclophosphamide; Female; Humans; L | 1989 |
Allogeneic bone marrow transplantation after high-dose busulfan and cyclophosphamide in patients with acute nonlymphocytic leukemia.
Topics: Acute Disease; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Drug Administration Schedule | 1989 |
Congenital metacarpal fusion associated with polydactyly.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Animals; Busulfan; Female; Fingers; Follow-Up | 1987 |
Major surgery in patients with polycythaemia vera.
Topics: Aged; Blood Platelets; Blood Transfusion, Autologous; Bloodletting; Busulfan; Erythrocyte Count; Fem | 1974 |
Abnormalities of platelet function in the myeloproliferative disorders.
Topics: Acute Disease; Adult; Blood Coagulation Tests; Blood Platelet Disorders; Busulfan; Female; Humans; L | 1972 |
Thrombocytosis. A source of increased bleeding tendency.
Topics: Aged; Blood Cell Count; Blood Platelets; Busulfan; Carcinoma; Colon, Sigmoid; Colonic Neoplasms; Div | 1973 |
The dangers of surgery in uncontrolled haemorrhagic thrombocythaemia.
Topics: Aged; Blood Cell Count; Blood Platelets; Busulfan; Hemorrhage; Humans; Male; Middle Aged; Peptic Ulc | 1970 |
[Present treatment of the Vaquez's disease].
Topics: Aged; Anemia; Anticoagulants; Antineoplastic Agents; Blood Donors; Blood Volume; Bloodletting; Busul | 1969 |